Reducing Peritonitis Rates in a Peritoneal Dialysis Program of Indigent Ethnic Minorities

United States Renal Data System. Bethesda, MD: US Department of Public Health and Human Services, Public Health Service, National Institutes of Health; 2001.

Korbet S.M. , Shih D. , Cline K.N. , Vonesh E.F. Racial differences in survival in an urban peritoneal dialysis program. Am J Kidney Dis 1999; 34: 713–20.

Keane W.F. , Bailie G.R. , Boeschoten E. , Gokal R. , Golper T.A. , Holmes C.J. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20: 828-9]. Perit Dial Int 2000; 20: 396–411.

Vonesh E. Modeling peritonitis rates and associated risk factors for individuals on continuous ambulatory peritonitis. Stat Med 1990; 9: 263–71.

Vonesh E.F. , Chinchilli V.M. Linear and Nonlinear Models for the Analysis of Repeated Measurements. New York: Marcel Dekker; 1997.

Bernardini J. , Piraino B. , Holley J. , Johnston J.R. , Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27: 695–700.

Thodis E. , Bhaskaran S. , Pasadakis P. , Bargman J.M. , Vas S.I. , Oreopoulos D.G. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site [see Comments]. Perit Dial Int 1998; 18: 261–70.

Casey M. , Taylor J. , Clinard P. , Graham A. , Mauck V. , Spainhour L. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients. Perit Dial Int 2000; 20: 566–8.